Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Latest reported FLGT revenue for 2026-06-30 was $156.5M. Net income was -$54.4M. FLGT currently screens at market cap $586.6M.
Use this FLGT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FLGT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FLGT SEC filings page. Lician reads the product cache first so this HTML stays unique to Fulgent Genetics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FLGT income, balance, and cash tables.